O

Oragenics

D
OGEN
USD
-0.0225
(-4.5126%)
Market Closed
2,300.00
Volume
-10.8
EPS
-
Div Yield
-0.064952
P/E
4,122,583.70
Market Cap
Today
-4.5126%
1 Week
-4.970%
1 Month
-53.551%
6 Months
-66.234%
12 Months
-84.642%
Year To Date
-91.791%
All Time
-99.830%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
O
OPNT
(%)
USD
E
EYPT
0.281
(3.1612%)
USD
O
ONCT
0.04
(2.3952%)
USD
MRNA
MRNA
-1.79
(-2.5637%)
USD
A
ABIO
(%)
USD
A
ASND
4.61
(3.0985%)
USD
V
VYNE
0.025
(1.3405%)
USD
P
PRVB
-0.075
(-0.313%)
USD
A
AKTX
0
(0%)
USD
B
BNGO
0.0207
(5.0748%)
USD

Title:
Oragenics

Sector:
Healthcare
Industry:
Biotechnology
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
Do you need help or have a question?
Contact Us